Literature DB >> 20961687

The development of fibromyalgia--I: examination of rates and predictors in patients with rheumatoid arthritis (RA).

Frederick Wolfe1, Winfried Häuser, Afton L Hassett, Robert S Katz, Brian T Walitt.   

Abstract

We determined rates and predictors of future development of fibromyalgia in patients with rheumatoid arthritis (RA). After excluding patients with fibromyalgia and those with high levels of fibromyalgia symptoms (fibromyalgianess score>10) at baseline, we studied fibromyalgia development in 9739 RA patients during 42,591 patient-years of follow-up. We defined fibromyalgia using a modification of the ACR 2010 fibromyalgia criteria. We used Cox regression to predict future fibromyalgia, and examined the accuracy of predictions using Harrell's C concordance coefficient. At the last observation, 7.4% of patients satisfied criteria, although 19.8% satisfied criteria at some point during follow-up, an incidence rate of 5.3 (95% CI 5.1, 5.6) per 100 patients years, and at rates that were similar in men (7.0%) and women (8.1%). Among those satisfying criteria, during 11,363 years of follow-up from the time of first fibromyalgia diagnosis, half of follow-up time was fibromyalgia+and was associated with markedly abnormal RA variable and FM variable scores. Demographic factors were weak predictors of fibromyalgia (C=0.604). Demographic plus RA variables (C=0.720) and demographic plus fibromyalgia variables (C=0.765), and all predictors (C=0.782) increased accuracy. Clinically important hazard ratios were noted for cognition, depression, comorbidity, and high levels of RA and FM continuous variables Overall, study results indicate that multiple, inter-correlated factors that include social disadvantage, psychological distress, comorbidity, RA severity, and fibromyalgia variables predict future development of fibromyalgia, but there is little evidence of the effect of underlying causes. After diagnosis, patients move in both directions across the diagnostic criteria cut points. Copyright Â
© 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20961687     DOI: 10.1016/j.pain.2010.09.027

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  52 in total

1.  [Etiology and pathophysiology of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Burgmer; R Engelhardt; K Gerhold; F Petzke; T Schmidt-Wilcke; M Späth; T Tölle; N Uçeyler; H Wang; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Piercarlo Sarzi-Puttini
Journal:  Rheumatol Int       Date:  2018-06-28       Impact factor: 2.631

Review 3.  Selective serotonin reuptake inhibitors for fibromyalgia syndrome.

Authors:  Brian Walitt; Gerard Urrútia; María Betina Nishishinya; Sarah E Cantrell; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2015-06-05

4.  Association Between Widespread Pain Scores and Functional Impairment and Health-Related Quality of Life in Clinical Samples of Children.

Authors:  Jennifer A Rabbitts; Amy Lewandowski Holley; Cornelius B Groenewald; Tonya M Palermo
Journal:  J Pain       Date:  2016-02-23       Impact factor: 5.820

5.  [How frequent are musculoskeletal diseases in Germany?].

Authors:  A Zink; K Albrecht
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

6.  Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients.

Authors:  Winfried Häuser; Eva-Maria Hoffmann; Frederick Wolfe; Angus B Worthing; Neil Stahl; Russell Rothenberg; Brian Walitt
Journal:  Clin Exp Rheumatol       Date:  2015-03-18       Impact factor: 4.473

Review 7.  Mechanisms, impact and management of pain in rheumatoid arthritis.

Authors:  David A Walsh; Daniel F McWilliams
Journal:  Nat Rev Rheumatol       Date:  2014-05-27       Impact factor: 20.543

Review 8.  Calcitonin gene-related peptide in the joint: contributions to pain and inflammation.

Authors:  David A Walsh; Paul I Mapp; Sara Kelly
Journal:  Br J Clin Pharmacol       Date:  2015-07-22       Impact factor: 4.335

9.  Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity.

Authors:  Sema Haliloglu; Ayse Carlioglu; Derya Akdeniz; Yasar Karaaslan; Ali Kosar
Journal:  Rheumatol Int       Date:  2014-03-04       Impact factor: 2.631

Review 10.  Central pain mechanisms in the rheumatic diseases: future directions.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.